Introduction {#S1}
============

Acute respiratory distress syndrome (ARDS) was initially thought to be a lethal double pneumonia and was identified as a syndrome by [@B7]. Unfortunately, in the 50 years since ARDS was identified, only a few treatments have been used, with the mainstay being supportive in the form of mechanical ventilation ([@B140]). However, mechanical ventilation constrained to the limitations of a heterogeneously injured lung can cause unintended tissue damage, referred to as ventilator-induced lung injury (VILI), which can significantly increase mortality (∼40%) as compared to lung protective ventilation (∼31%) ([@B6]). Initial randomized controlled trials (RCTs) attempting to reduce VILI by lowering tidal volume (Vt) failed to reduce mortality ([@B143]; [@B18]). It was not until the ARDS Network (ARDSnet) conducted the seminal ARMA study, published in 2000, that a reduction in mortality was shown ([@B6]). However, most ([@B119]; [@B153]; [@B25]; [@B9]; [@B80]; [@B154]; [@B87]; [@B125]; [@B127]; [@B45]; [@B95]; [@B118]; [@B138]) but not all ([@B19]; [@B47]; [@B123]; [@B117]; [@B138]) of the recent statistical- and meta-analyses have shown that ARDS mortality has not been reduced below the 31% "gold standard" of the 2000 ARMA study but rather remains unacceptably high at ∼40% ([Figure 1](#F1){ref-type="fig"}). Despite these disappointing results, the low-Vt ARDSnet method is still recommended as the standard-of-care protective ventilation strategy for ARDS patients ([@B46], [@B45]; [@B113]).

![**(A)** Hospital mortality (%) in the main epidemiological studies for all three American-European Consensus Conference (AECC) classifications of acute respiratory distress syndrome (ARDS -- mild, moderate, and severe) and **(B)** mortality (%) for only moderate and severe ARDS. The mean and standard deviation for mortality in all of the studies following the 2000 ARMA study ([@B6]) is 45.4 ± 9.5 ([@B127]). *Permissions obtained from AME Publishing Company, License ID 1017423-1.*](fphys-11-00227-g001){#F1}

Since outcome data for ARDS patients has not improved for almost 20 years, it is imperative to (1) ascertain the mechanisms of dynamic alveolar and alveolar duct volume change during mechanical ventilation (elastic, viscous, or viscoelastic), (2) characterize ARDS-induced changes in alveolar mechanics (i.e., the dynamic change in alveolar size and shape during mechanical ventilation) ([@B60]) that drive VILI-induced tissue damage, (3) identify the role of airway pressure and the duration at both inspiration and expiration on alveolar mechanics in the acutely injured lung ([@B75], [@B79]), and (4) use this knowledge to develop novel ventilation strategies to better reduce VILI and protect the lung. Although pulmonary inflammation (biotrauma) also plays a critical role in ARDS and VILI pathogenesis, the focus of this review will be the mechanical injury to tissue caused during ventilation.

Constraints of Ventilating the Acutely Injured Lung {#S2}
===================================================

The current concept is that ARDS causes heterogeneous injury in three general lung compartments that are layered by gravity ([Figure 2](#F2){ref-type="fig"}). The first compartment, or the non-dependent area, contains a small number of normal compliant alveoli that remain inflated at end-expiration---functional residual capacity (FRC)---and is referred to as the "baby lung" ([@B56]). The second compartment consists of alveoli in the dependent areas that are collapsed and/or edema filled. The third compartment consists of alveoli that remain in the transition zone between healthy and unstable, due to loss of surfactant function, and that open and collapse with every breath.

![Gravity dependent three-compartment model of acute respiratory distress syndrome (ARDS) pathology: **Left** -- Physiological mechanisms of ventilator-induced lung injury (VILI) and **Right** -- Potential beneficial mechanisms of various protective ventilation strategies to minimize VILI. Open alveoli are shown as blue circles similar in size (top), unstable alveoli as smaller circles of various sizes (middle), and collapsed alveoli as solid white lines (bottom). The ARDSnet low tidal volume (LVt) method is designed to *protect* compliant open alveoli in the non-dependent lung and *rest* the collapsed tissue in the dependent portion of the lung by keeping it unventilated. Positive end-expiratory pressure (PEEP) is added in an attempt to *stabilize* the alveoli in between ([@B6]). High-frequency oscillatory ventilation (HFOV) and lung recruitment maneuvers (LRMs) have been shown ineffective in reducing ARDS mortality ([@B17]; [@B97]; [@B99]; [@B51]; [@B162]; [@B26]; [@B68]). Prone position has been shown effective at reducing mortality ([@B61]) by a mechanism of reducing regional alveolar strain and inflammation ([@B101]; [@B160]). VILI, ventilator-induced lung injury; MV, mechanical ventilation; LTV, low tidal volume and inspiratory pressure; PEEP, positive end-expiratory pressure; ECLS, extracorporeal life support; HFOV, high-frequency oscillatory ventilation; LRM, lung recruitment maneuver; Q, perfusion; V~A~, alveolar ventilation; V~A~/Q, ventilation/perfusion ratio; baby lung, functional residual capacity (FRC) ([@B39]). *Permissions to publish obtained from ATS.*](fphys-11-00227-g002){#F2}

Consequently, the ARDSnet low-Vt and plateau pressure (Pplat) strategy is constrained to ventilating this heterogeneous lung tissue without causing VILI using a three-tiered approach: (1) *protect* the baby lung by not overdistending the compliant tissue that is open at FRC, (2) *rest* the dependent collapsed and edema-filled tissue by keeping it out of the ventilatory cycle, and (3) *stabilize* the tissue in between by applying positive end-expiratory pressure (PEEP), usually adjusted by oxygenation ([Figure 2](#F2){ref-type="fig"}) ([@B6]; [@B39]).

Problems With Protecting the Baby Lung {#S2.SS1}
--------------------------------------

Since the baby lung is believed to be a small volume of normal tissue ([@B56]), its overdistension has been postulated to be a primary VILI mechanism ([@B17]). However, in studies in which normal lungs were subjected to excessively high airway pressures (\>30 cm H~2~O) and strain (2.5 ratio), overdistension-induced VILI did not occur as long as this excessive strain was nearly static. This suggests that overdistension of normal tissue with high volume and pressure is not a primary VILI mechanism unless there is also a large dynamic strain ([@B137]; [@B121]; [@B71]). It is possible that the baby lung is injured not by overdistension of the normal tissue, but rather by the recruiting and recollapse of unstable tissue in the adjacent collapsed regions ([@B55]). Thus, lowering Vt and Pplat to reduce overdistension in the open lung tissue, which is surrounded by a large volume of collapsed and unstable tissue of very low compliance, may not reduce VILI. Regional instability and inflammation occur throughout the entire lung, including in tissue that appears to be normal on computed tomography (CT) scan or chest X-ray, and serve as pathologic focal points from which VILI-induced tissue damage expands ([@B157], [@B156]; [@B31], [@B29]). This suggests that to protect the normal lung tissue regional instability must be eliminated.

However, others have shown that overdistension is a major component of VILI pathophysiology in injured lungs ([@B62]). [@B62], in a porcine ARDS model, showed that extreme conditions of overdistension resulted in more lung inflammation than did extreme lung collapse, suggesting that static stress and strain are major VILI mechanisms. Although this study clearly showed that volutrauma increased inflammation, histopathology was not measured, and there was no difference in pulmonary edema as measured by lung weight. Thus, it is not clear whether the increase in inflammation caused any lung pathology. In addition, recalculation of the data showed that the average mechanical power in the volutrauma group was 17.12 J/min, more than double that of the atelectrauma group (7.13 J/min) ([@B151]). Others have also shown that increasing airway pressure in an acutely injured lung will cause a rapid progression of injury in a "rich-get-richer" power-law fashion, supporting the findings in the Guldner study ([@B65]). Combined, these studies suggest that high static stress and strain are associated with volutrauma in acutely injured lung tissue but not in normal lung tissue.

Problems With Resting the Collapsed Lung {#S2.SS2}
----------------------------------------

When the lung is allowed to collapse below normal FRC, atelectatic, and edema-filled *resting* tissue (1) does not exchange gas; (2) is susceptible to the development of pneumonia ([@B69]; [@B83]); (3) will become fibrotic if not reopened ([@B20]; [@B22]; [@B86]); (4) initiates patient-ventilator dyssynchrony, which is caused by the firing of mechanical stretch, PO~2~, PCO~2~, and pH receptors ([@B142]; [@B92]; [@B158]; [@B98]; [@B21]; [@B163]; [@B161]) and which is associated with high mortality ([@B13]); and (5) creates a stress-focus in the adjacent open alveoli and alveolar ducts, greatly amplifying the forces applied to these parenchymal tissues during tidal ventilation ([@B96]; [@B53]; [@B34]; [@B91]; [@B126]). It has been shown that letting the lung *rest* in obese bariatric surgery patients is associated with worse oxygenation, longer post-anesthesia care unit stay, and more post-operative pulmonary complications as compared with patients in which the atelectatic *resting* lung was opened and ventilated ([@B148]). Although, the phrase *resting* the lung sounds protective, the lung is not meant to function in a deflated state, and as listed above, such a state is associated with numerous pathologies. If the lung is to be *rested*, meaning that parenchymal tissue is to be kept from being damaged by mechanical ventilation, the better strategy would be to *rest* it in the natural inflated state ([@B108]).

Problems With Stabilizing the Lung {#S2.SS3}
----------------------------------

There is no consensus on how best to set PEEP to effectively *stabilize* lung tissue ([@B33]; [@B54]; [@B111]; [@B10]). The current ARDSnet method for setting PEEP uses a sliding scale of oxygenation ([@B6]), but increased oxygenation does not correlate well with an increase in alveolar stability ([@B4]), a key VILI mechanism ([@B157], [@B156]; [@B31], [@B29]). Many methods have been used in an attempt to titrate the PEEP to stabilize lung tissue. These methods include using dead space, lung stress and strain, lung compliance, CT, pressure-volume curve inflection points, and electrical impedance tomography, but there is no current bedside technique to determine whether the set PEEP has actually stabilized the lung ([@B111]). The above problems with the ARDSnet *protect*, *rest*, and *stabilize* method may partially explain the lack of improved outcome in ARDS mortality over the last 20 years ([Figure 1](#F1){ref-type="fig"}) ([@B19]; [@B119]; [@B153]; [@B25]; [@B9]; [@B80]; [@B154]; [@B87]; [@B125]; [@B127]; [@B45]; [@B95]; [@B118]). By allowing the lung to remain heterogeneously collapsed, the *protect*, *rest*, and *stabilize* method is unintendedly preserving the constraints of ventilating the heterogeneously injured lung, which is nearly impossible to do without causing some degree of VILI.

Open Lung Approach (OLA) as a Protective Strategy {#S2.SS4}
-------------------------------------------------

The goal of the open lung approach (OLA) is to eliminate the constraints of ventilating a heterogeneously injured lung by normalizing all three pathologic compartments ([Figure 2](#F2){ref-type="fig"}). The aim is to reinflate the collapsed tissue using a recruitment maneuver (RM) and to keep it open by using an appropriate level of PEEP. If the entire lung could be recruited and recollapse prevented, the main VILI mechanical mechanisms (dynamic strain and overdistension of alveolar walls in areas of stress-focus) would be eliminated ([@B112]). An RM is an acute event performed by raising the airway pressure (30--40 cm H~2~O) and holding it for ∼40 s ([@B48]) or by greatly increasing PEEP (25 cm H~2~O) and combining it with 15 cm H~2~O of driving pressure above the PEEP ([@B15]). In the latter strategy, PEEP is increased in 5 cm H~2~O increments up to 45 cm H~2~O until the lung fully recruits, which was confirmed when PaO~2~ + PaCO~2~ \> 400 mmHg ([@B15]).

Following the RM, PEEP is titrated downward to find the lung recollapse point (usually by a sharp fall in lung compliance), and then PEEP is set 2 cm H~2~O above this collapse pressure, following a second RM. However, multiple RCTs testing the OLA in ARDS patients have failed to show significant benefits over standard of care ([@B17]; [@B97]; [@B99]; [@B26]; [@B68]). Reasons for these failures include the following: (1) timing of OLA application \[early ([@B15]) vs. late ([@B52])\] (2) one-size-fits-all RM strategies, (3) PEEP set inappropriately to keep the recruited lung open, (4) recruiting pressures insufficient to open all of the lung, (5) a patient population of responders (lung recruits) and non-responders (lung does not recruit) ([@B52]), and (6) application of OLA not as a continuous treatment but rather as a one-time event with a long time period before a second application or with no second application at all ([@B59]; [@B85]; [@B11]; [@B37]; [@B68]; [@B72]; [@B152]; [@B164]). Most ([@B11]; [@B37]; [@B68]; [@B72]; [@B164]) but not all ([@B59]; [@B85]) meta-analyses have shown no decrease in ARDS-related mortality associated with the OLA.

To further reduce ARDS mortality and acute lung injury, two pathologic processes must be understood: (1) the pathophysiology of ARDS that predisposes the lung to a secondary VILI and (2) the mechanisms of VILI in the microenvironment (i.e., the terminal airspaces, alveoli, and alveolar ducts). This knowledge informs the design of a protective mechanical breath that will allow the lung to heal by eliminating the constraints present when ventilating a heterogeneously injured lung ([@B108]).

ARDS Pathophysiology That Predisposes the Lung to VILI {#S3}
======================================================

ARDS Is a Pathologic Tetrad {#S3.SS1}
---------------------------

To investigate the relationship between ARDS and VILI, we need to understand the pathology of acute lung injury. Although ARDS is a complex syndrome, it features four well-accepted central components ([@B149]) known as the "pathologic tetrad" ([Figure 3](#F3){ref-type="fig"}) ([@B108]). The components of the tetrad include *increased pulmonary capillary permeability* ([Figure 3](#F3){ref-type="fig"}, Endothelial Leakage), which if unchecked will lead to *loss of surfactant function* ([Figure 3](#F3){ref-type="fig"}, Surfactant Deactivation) ([@B82]). The resultant high alveolar surface tension will exacerbate the permeability-induced increase in *alveolar flooding* with edema fluid ([Figure 3](#F3){ref-type="fig"}, Alveolar Edema) ([@B109]). Surfactant dysfunction will alter alveolar mechanics, resulting in alveolar *recruitment/derecruitment (R/D)* with each breath ([Figure 3](#F3){ref-type="fig"}, R/D) ([@B136]). Each component of the tetrad has a profound impact on alveolar mechanics. Surfactant deactivation sets the stage for a secondary VILI by promoting heterogeneous lung tissue instability and collapse. In addition, surfactant secretions from type II cells would be inhibited in collapsed areas that are not being stretched during ventilation ([@B159]; [@B90]). Reduced surfactant secretion would exacerbate and perpetuate the already reduced surfactant function caused by alveolar flooding with edema.

![The *pathologic tetrad* of acute respiratory distress syndrome (ARDS). Alveolar walls contain pulmonary capillaries (red circles) and are lined with a liquid hypophase (blue layer inside each alveolus), with an intact pulmonary surfactant layer (small blue ball with tail) layered on the hypophase. The systemic inflammatory response syndrome (SIRS) secondary to sepsis, trauma, burns, pneumonia, and so on increases pulmonary capillary permeability. **Endothelial leakage:** increased microvascular permeability allowing pulmonary edema to move into the alveolus (black arrows and tan edema blebs) ([@B94]). **Surfactant deactivation:** the continuous layer of pulmonary surfactant molecules is disrupted as the edema blebs expand causing surfactant deactivation (surfactant sluffing off into the alveolar space). Edema usurping surfactant from the alveolar surface, the proteins in the edema fluid deactivating the surfactant ([@B146]), and improper mechanical ventilation ([@B1]) causing further surfactant disruption all combine to exacerbate surfactant loss. **Alveolar edema:** increased capillary permeability ([@B94]) and high alveolar surface tension combine to flood alveoli with edema fluid (tan). **Recruitment**/**derecruitment** (**R**/**D**): loss of surfactant function results in increased alveolar surface tension causing loss of alveolar stability (i.e., causing alveolar R/D with each breath). Alveoli in the top frame of **R/D** are fully inflated but collapse during expiration in the bottom **R/D** frame. Alveolar R/D, known as atelectrauma, is another key VILI mechanism ([@B35]). **Stress-focus**: edema-filled or collapsed alveoli adjacent to air-filled alveoli create a stress-focus causing the alveolar wall to bend toward the fluid-filled alveolus (green arrow), which can cause stress failure at the alveolar wall ([@B115]). Stress-focus is another key mechanism of VILI ([@B115]; [@B32]; [@B91]; [@B126]). Thus, the *pathologic tetrad* sets up a vicious cycle of high microvascular permeability → edema → surfactant deactivation → high alveolar surface tension → more edema → alveolar R/D → further increase in microvascular permeability → severe ARDS ([@B109]).](fphys-11-00227-g003){#F3}

VILI Mechanisms: Heterogeneous Alveolar Instability and Collapse {#S4}
================================================================

The hallmark of ARDS is a heterogeneous lung injury encompassing normal, collapsed, edematous, and unstable tissues ([Figure 2](#F2){ref-type="fig"}). This pathology alters pulmonary microanatomy and dynamic alveolar inflation physiology, generating three basic VILI mechanisms: *volutrauma* (overdistension of airways), *atelectrauma* (R/D of alveoli), and *biotrauma* (inflammation) ([@B149]). From an engineering perspective, volutrauma is caused by excessive static strain and atelectrauma by excessive dynamic strain ([@B137]; [@B120], [@B121], [@B122]). In this review we do not discuss biotrauma but rather focus on the unintentional mechanical damage to the pulmonary parenchyma caused during mechanical ventilation.

Mechanical ventilation of the acutely injured lung with altered alveolar opening and collapse time constants can cause tissue stress-failure by the following mechanisms: (1) alveolar R/D-induced excessive stress on the epithelial cells as the alveolar walls in apposition peel apart ([@B12]), (2) stress-focusing in areas of open alveoli adjacent to collapsed or edema fill alveoli ([@B53]; [@B34]; [@B126]), and (3) collapsed tissue stretching and overdistending the shared walls of patent alveoli, as alveolar walls are interconnected ([Figure 4](#F4){ref-type="fig"}) ([@B112]). Theoretically, if it were possible to minimize or prevent all of the above VILI mechanisms, ARDS associated mortality would be significantly reduced.

![Mechanical mechanisms of ventilator-induced lung injury (VILI) in the microenvironment: Left -- *In vivo* subpleural alveoli in an acutely injured rat lung at inspiration **(a)** and expiration **(b)**. Lung histology in the same rat lung injury model fixed at inspiration **(c)** and expiration **(d)** ([@B114]). *Alveolar recruitment/derecruitment (R/D)* causing atelectrauma can be seen as fully recruited alveoli filling the microscopic field (white circles, two of which are highlighted with black dotted line) **(a)** that collapse during expiration (red atelectatic areas highlighted by arrows) **(b)**. Histology shows open alveoli at inspiration with a shared alveolar wall highlighted by arrows **(c)** that collapse with expiration by alveolar wall folding, identified by arrows. Right -- *Stress-focus (SF)* in areas with collapsed alveoli. SF adjacent to open alveolar ducts, causing alveolar duct *overdistension (OD)*. SF-induced OD causes excessive mechanical stress and strain on alveolar duct walls, resulting in damage to pulmonary parenchymal cells ([@B58]). Loss of surfactant function results in alveolar instability ([Figure 3](#F3){ref-type="fig"}, R/D). Histology at exhalation in a rat Tween-induced surfactant deactivation model with a tidal volume of 6 ml/kg and a PEEP of 5 cm H~2~O. Note the heterogeneous collapse of alveoli causing areas of stress-focus (SF). Adjacent to these areas of SF are overdistended (OD) alveolar ducts ([@B76]). Summary -- R/D causes excessive normal or "peeling" stress as the adhered alveolar walls peel apart during inflation; both R/D and SF cause OD in adjacent open stable tissue. This excessive stress and strain on alveolar walls results in lung parenchymal cell death and is a major VILI mechanism. *Permissions obtained to reuse panels* **(a--d)** ([@B114]). *Springer Nature license number 4766000130978.*](fphys-11-00227-g004){#F4}

In normal pigs ventilated for 54 h, [@B121] examined the impact of high static strain and several levels of dynamic strain. They demonstrated that *high static strain*, using elevated PEEP and minimal Vt, caused little damage, but when PEEP was reduced, producing a *high dynamic strain*, it caused pulmonary edema and death. In subsequent work they showed that high static strain did not merely act as a dam to prevent edema formation by altering the Starling forces (i.e., increasing the pulmonary interstitial pressure) ([@B42]) but rather preserved the integrity of the alveolar-capillary membrane ([Figure 3](#F3){ref-type="fig"}, Endothelial Leakage) ([@B120]). These findings were supported by [@B71] using a porcine heterogeneous lung injury model. They subjected two study groups to high static strain (Pplat = 40 cm H~2~O) that was believed to be more than sufficient to cause volutrauma-induced VILI ([@B6]; [@B134]). Following heterogeneous lung injury, the animals in the second group were also subjected to high dynamic strain. High static strain did not injure normal open tissue (baby lung), nor did it exacerbate acutely injured tissue. However, combining high static strain with high dynamic strain caused significant damage to both of these tissues ([Figure 5](#F5){ref-type="fig"}). Further support for the contention that volutrauma of normal lung tissue is not a primary VILI mechanism comes from the Bates group, who showed that 4 h of mechanical ventilation in mice with high static strain was not associated with lung injury, but when it was combined with high dynamic strain, it caused VILI-induced tissue damage ([@B137]).

![Heterogeneous Tween Injury in pigs ventilated for 6 h. A bronchoscope was used to deliver Tween to the dependent areas of the diaphragmatic or caudal lung lobes. Thus, the upper lobes would be normal homogeneously inflated tissue (i.e., would simulate the baby lung), and the dependent areas of the caudal lobe would model acutely injured tissue that would be either collapsed or unstable during tidal ventilation. Using this injury model we can determine whether a ventilation strategy protects either normal tissue (N~T~) or acutely injured lung tissue (ALI~T~), protects neither, or protects both. Two groups were studied. Both groups were subjected to a high static strain (Pplat = 40 cm H~2~O) hypothesized to be sufficient to cause overdistension (OD)-induced VILI to the baby lung ([@B6]). One group was also subject to high dynamic strain (H~DS~) and the other to low dynamic strain (L~DS~). The dynamic strain was adjusted using the airway pressure release ventilation (APRV) mode by changing the expiratory duration, which changed tidal volume size. Left -- Gross photographs of the whole lung **(A,B)** and cut surface **(C,D)** of the diaphragmatic lung lobe. The L~DS~ group **(A,C)** showed minimal damage in both N~T~ and ALI~T~ lung tissue (i.e., no dark red hepatized atelectasis). This was in contrast to the H~DS~ group, in which there was severe injury in both the N~T~ and ALI~T~ lung tissues **(B,D)**. Right -- In the OD + H~DS~ group (OD + H~DS~), widespread histopathology typical of ARDS was seen, with inflammatory cell inflation (arrows) and fibrin deposits (arrowheads) in both the N~T~ and ALI~T~ lung tissue. In the OD + L~DS~ group, minimal histopathology was seen, and alveoli remained open (stars) in both N~T~ and ALI~T~ lung tissue. These data support [@B121] work and demonstrate that normal lung tissue is highly resistant to static strain-induced volutrauma. In addition, this study showed that acutely injured lung tissue is also resistant to volutrauma as long as dynamic strain remains low. Both normal and acutely injured lung tissue are highly susceptible to high alveolar R/D-induced VILI when under high inflation pressure ([@B71]). These data support the rapid progression of lung injury in a power-law fashion when high static and dynamic strain are combined ([@B65]).](fphys-11-00227-g005){#F5}

[@B122] showed that a large dynamic strain (atelectrauma) is much more harmful to the normal lung than a large static strain (volutrauma), and when combined, the two work additively or synergistically to greatly accelerate tissue damage ([@B137]; [@B66]; [@B131]). In addition, the heterogeneous injury caused by ARDS establishes many areas of *stress-focus* between the open tissue and collapsed or unstable tissue and have been shown to double the stress and strain calculated for the entire lung ([@B34]). The impact that areas of stress-focus have on the forces generated on alveolar walls during ventilation was first described by [@B96] and was more recently analyzed by [@B91] using computer-simulated alveolar walls. This latter group demonstrated that a Pplat at the upper end of the "safe" level (30 cm H~2~O) could result in a local stress-focusing in individual alveolar walls of up to 48 cm H~2~O and could concentrate stress in an individual alveolar wall as much as 16-fold ([Figure 6](#F6){ref-type="fig"}).

![A two-dimensional finite element computational model of interconnected alveolar walls to study the impact of areas of stress-focus (S-F) on stress--strain relationships. Both a hexagonal honeycomb (top) and Voroni honeycombs (bottom) were studied with areas of S-F created by increasing the stiff regions in one **(A)** or nine **(B)** cells. These stiff regions simulate collapsed alveoli adjacent to open alveoli that create an S-F in acute respiratory distress syndrome (ARDS) patients ([Figure 4](#F4){ref-type="fig"}) ([@B34]). The entire honeycomb structure was expanded and exposed to strains of 15, 30, 45, and 55% above the resting geometry. Some of the alveolar walls in the Voroni honeycomb were exposed to a S-F ∼16 times greater than that applied to uniformly expanded areas. This suggests that ventilation pressures considered safe in ARDS patients (\<30 cm H~2~O) ([@B6]) could be causing local stress concentration on some alveolar walls of approximately 48 cm H~2~O, with even higher stress in areas of S-F ([@B91]). *Permissions obtained from Elsevier. License 4699410294890.*](fphys-11-00227-g006){#F6}

In summary, ARDS results in a heterogeneous loss of surfactant function ([Figure 3](#F3){ref-type="fig"}, Surfactant Deactivation) and airway flooding ([Figure 3](#F3){ref-type="fig"}, Alveolar Edema) that cause the lung to become *time and pressure dependent*, which means that the lung will collapse in a relatively short time at atmospheric pressure and will require a longer period of time to open even at high inflation pressures ([@B147]). Mechanical ventilation can exacerbate the initial ARDS-induced inflammatory injury ([Figure 3](#F3){ref-type="fig"}, Endothelial Leakage, Surfactant Deactivation, and Alveolar Edema) by generating excessive stress and strain on alveolar and alveolar duct walls resulting from a collapsing and reopening of alveoli and heterogeneous areas of stress-focusing in open tissue adjacent to collapsed or edema-filled tissue ([Figure 4](#F4){ref-type="fig"}).

It is important to note that parenchymal overdistension following acute lung injury is a regional phenomenon and occurs only in open alveoli and alveolar ducts that are adjacent to the unstable or collapsed tissue ([Figure 7](#F7){ref-type="fig"}, PEEP 16, PEEP 5, APRV 10%); it does not occur in homogeneously inflated acutely injured lung tissue ([Figure 7](#F7){ref-type="fig"}, APRV 75%) ([@B112]). It has been shown that combining high pressure with alveolar instability greatly exacerbates tissue tearing in a rich-get-richer fashion (i.e., the larger the initial tear in the epithelial membrane the more that this tear will be expanded by increased airway pressure) ([Figure 8](#F8){ref-type="fig"}) ([@B66]; [@B131]).

![Rat lungs fixed at inspiration and expiration in normal lungs (**Control**) and in a Tween lavage ARDS model with four ventilation strategies: (1) the TCAV method setting airway pressure release ventilation (APRV) with the expiratory flow termination (E~FT~) at 75% of expiratory flow peak (E~FP~) (E~FT~/E~FP~ = 75%) (**APRV 75%**) ([@B63]; [@B70]); (2) E~FT~/E~FP~ = 10% (**APRV 10%**), which significantly increased expiratory time; (3) controlled mandatory ventilation (CMV) with low tidal volume (6 mL/kg) with 5 cm H~2~O positive end-expiratory pressure (**PEEP 5**); or (4) CMV with low tidal volume (6 mL/kg) with 16 cm H~2~O PEEP (**PEEP 16**). **APRV 10%** (not the TCAV method) significantly increased expiratory duration, allowing sufficient time for alveoli to collapse. The conducting airways are depicted in green; alveoli in lilac; and remaining interstitium, blood vessels, and lymphatics in magenta. The size of each microanatomical area was quantified using computer image analysis. In the **Control** group all alveoli were inflated surrounding normally distended alveolar ducts. Following Tween-induced ARDS, alveolar ducts in all ventilation groups were increased in size. In the CMV groups alveolar ducts were overdistended at both inspiration and expiration in **PEEP16.** In the **PEEP5** group alveolar ducts were relatively normal size at expiration but greatly overdistended at inspiration with areas of alveolar collapse (i.e., high dynamic strain) at both inspiration and expiration. **APRV 10%** resulted in highly overdistended alveolar ducts at both inspiration and expiration with large areas of collapsed alveoli. **APRV 75%** (i.e., the TCAV method) resulted in the smallest increase in alveolar duct size, with uniformly open, homogeneously ventilated alveoli that were closest to those seen in the **Control** group ([@B76]). *Permissions obtained from Elsevier. License 4732510649425.*](fphys-11-00227-g007){#F7}

![Panels **(A--F)** depict leak progression caused by an applied stretch force. A single node fails (nf) at each time point with nf indicating the number of nodes that have failed in each panel. Computational model of an epithelial monolayer to simulate leak progression due to overdistension. Leak progression in a 45-cell (hexagon) network caused by applied stretch (i.e., Vt). After the force required to initiate the leak was reached, the leak area increased at a constant rate as the force increased further ([@B66]). Atelectrauma caused the initial tears, after which volutrauma expanded those tears. The tears progressed in a rich-get-richer mechanism in which the likelihood of a tear getting larger increased with the size of the initial tear. This mechanism explains why atelectrauma appears to be essential to the initiation of VILI in a normal lung, and why atelectrauma and volutrauma act synergistically once VILI is underway ([@B65]). *Permissions obtained from Springer Nature. License 4699410825602.*](fphys-11-00227-g008){#F8}

Ventilating Within the Constraints of an Acutely Injured Lung {#S5}
=============================================================

The ARDSnet method is a logical physiologically based lung ventilation strategy within the constraints of protecting a heterogeneously injured lung. The better strategy would be to eliminate these constraints by opening and stabilizing the acutely injured lung or, better yet, by applying a protective ventilation strategy early and never letting the lung collapse ([@B135]). Gattinoni and Pesenti stressed that in a patient with ARDS the Vt should not be set by body weight (Vt/kg ratio) but rather by the size of the remaining normal open tissue at FRC: the baby lung (Vt/baby lung volume ratio) ([@B56]). They hypothesized that the baby lung was the small amount of open tissue at end-expiration (i.e., FRC) surrounded by a large volume of collapsed tissue with very low compliance. Since the specific elastance \[E~spec~ = transpulmonary pressure (Ptp)/Vt x baby lung volume, which is the airway pressure at which expiratory lung volume or FRC or baby lung volume doubles in size (i.e., when Vt/baby lung volume = 1)\] if the baby lung is postulated to be normal, there would be a greater potential for overdistension in normal lung tissue because of the high compliance at any given level of static strain ([@B56]). Both the potential of excessive stress (Ptp) to cause volutrauma and of excessive strain (Vt/end-expiratory lung volume) to cause atelectrauma are linked with the following equation:
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Gattinoni and Pesenti further concluded that the above equation suggests the baby lung must be treated gently, using low Vt, low Ptp, and proning so as not to cause volutrauma. Gently ventilating the lung should be protective, within the constraints of a heterogeneously injured lung (i.e., high E~spec~ and low baby lung volume).

The current strategy of lung protection is designed to minimize normal tissue overdistention (low Vt) and to stabilize (PEEP) injured tissue. Although the current hypothesis is that the primary mechanism of VILI is overdistension of the baby lung ([@B6]), recent studies have demonstrated that high Ptp does not result in injury to normal lung tissue ([@B137]; [@B120], [@B121], [@B122]; [@B71]). Since much of the lung remains collapsed and unstable using the ARDSnet method, there are numerous areas of stress-focus, as PEEP adjusted by changes in oxygenation may not be adequate to prevent R/D ([@B8]; [@B14]). Even with low Vt, tissue injury may occur regionally, since overdistension is not global but occurs in the microenvironment. Specifically, alveolar and alveolar duct overdistension occurs in open tissue surrounding a collapsed area of stress-focus or adjacent to areas of alveolar instability ([Figures 4](#F4){ref-type="fig"}, [6](#F6){ref-type="fig"}, [7](#F7){ref-type="fig"}) ([@B96]; [@B27], [@B28], [@B30]; [@B76], [@B79]; [@B91]; [@B112]; [@B131]). Indeed, it has been shown that atelectasis, not high Vt, causes overdistension

in the adjacent patent alveoli and that alveolar size actually decreases with increased airway pressure (i.e., PEEP) if lung tissue is recruited by a mechanism of gas redistribution ([@B27], [@B28], [@B30]). It has also been shown that gas redistribution in the microenvironment is not only *pressure* dependent but also *time* dependent (i.e., the longer the pressure is applied, the better the gas redistribution) ([Figure 7](#F7){ref-type="fig"}) ([@B76]).

Animal studies have shown that the OLA can protect the lung from VILI even if ΔP is not reduced ([@B150]). Recruiting the lung with PEEP has been shown to reduce tissue damage secondary to spontaneous breathing (SB) by two mechanisms: (1) the intensity of the SB is reduced via neuromechanical uncoupling, and (2) the reduced amount of atelectatic tissue decreases the volume of stress-focus areas ([@B100]). Other studies using animal models have also shown the physiologic and pathologic benefit of opening the acutely injured lung ([@B50]; [@B155]; [@B41]; [@B102]; [@B103]; [@B110]; [@B88]). Additionally, animal studies have shown that to successfully implement the OLA, the RM and subsequent PEEP level must be applied properly, or the approach may actually increase lung damage. [@B49] showed that an RM increased lung pathology if PEEP was not set sufficiently high to prevent recollapse of the newly opened tissue, a finding that is supported by direct *in vivo* observation of subpleural alveoli ([@B64]). In light of this evidence, discarding the OLA does not seem logical, since it is unclear whether the RCTs testing the OLA actually opened and stabilized the lung. A better strategy might be to identify ventilation strategies that are most likely to accomplish the goals of the OLA ([@B133]).

A Physiologically Informed Strategy to Effectively Open and Stabilize the Lung {#S6}
==============================================================================

Surfactant deactivation and edema flooding with acute lung injury cause alveolar collapse; the result is very "sticky" and does not reopen easily ([Figure 3](#F3){ref-type="fig"}) ([@B36]; [@B57]). This tissue has a very long opening time constant, and thus it will take an extended period of time at any given pressure to recruit these surfactant deficient and edematous tissues. Once the collapsed alveoli are recruited, the opposite problem develops; the newly opened alveoli have a very brief collapse time constant ([@B105], [@B106], [@B104]). Thus, alveoli collapse quickly (≤0.5 s) once a critical collapse airway pressure is reached (i.e., collapse is *time* and *pressure* dependent) ([@B75], [@B76]).

To effectively implement the OLA, the entire mechanical breath pattern (MB~P~), including all airway volumes, flows, pressure, rates, and the times during which they apply during inspiration and expiration, must be analyzed ([@B75]). The current OLA ventilation strategies do not consider the pathophysiological changes that occur in alveolar opening and collapse time constants. Attempting to recruit large volumes of collapsed lung with a single RM over a very brief period of time is often not physiologically possible depending on the degree of surfactant damage and edema. A more effective strategy may be a ventilation method that "nudges" the lung open over an extended period of time (6--24 h) using a high mean airway pressure held for most of each breath. Likewise, the very fast alveolar collapse time constants are not considered when setting PEEP with expiratory durations in the 2- to 3-s range. A more effective strategy may be to use a ventilator method with a very brief (≤0.5 s) expiratory time while maintaining a level of time-controlled PEEP (TC-PEEP). Greatly limiting the expiratory duration (≤0.5 s) keeps the lung from emptying completely, maintaining a TC-PEEP that is related to expiratory duration and the collapse time constant of the lung. Thus, for any given collapse time constant, the shorter the expiratory time, the higher the TC-PEEP and vice versa. In addition, since alveolar collapse is viscoelastic in nature ([Figure 9](#F9){ref-type="fig"}), the very short expiratory duration would work synergistically with TC-PEEP to prevent alveolar collapse -- alveoli simply would not have sufficient time to derecruit ([@B107]). Analysis of the change in alveolar opening and collapse time constants with acute lung injury suggests that the time component of the MB~P~ ([@B75]) can be used to improve the ability to recruit and stabilize acutely injured lung tissue, which is necessary to successfully implement the OLA.

![Viscoelastic behavior of alveolar recruitment and derecruitment described using a spring and dashpot model. During inspiration the spring is rapidly stretched, whereas the dash in the pot moves more slowly as fluid squeezes around it (brown arrows), in response to the applied force (i.e., tidal volume -- red bar). The effect of this viscoelastic behavior is continual alveolar recruitment as long as inspiration is held (open lung/time curve). Viscoelastic behavior during expiration shows a rapid collapse of the spring and a much slower collapse of the dash in the pot. This is shown in the open lung/time curve as continuous alveolar collapse or derecruitment over time. Viscoelastic alveolar opening and collapse suggests that the longer inspiration is held, the more alveoli are recruited, and the shorter the expiratory time, the fewer the alveoli that collapse.](fphys-11-00227-g009){#F9}

In addition to the time component of MB~P~, the dynamic physiology of alveolar R/D must also be understood to design a mechanical breath for the OLA. Alveoli and alveolar ducts inflate and deflate as a viscoelastic system ([@B40]; [@B44]; [@B49]; [@B24]; [@B145]; [@B112]). The model most used to analyze viscoelastic behavior is the spring and dashpot ([Figure 9](#F9){ref-type="fig"}). The most important thing to know about a viscoelastic system, in relation to lung opening and collapse, is that there is a time lag from when the force (inspiratory pressure) is applied until alveoli begins to open and a lag between when force is removed (expiratory pressure) and when alveoli begin to collapse. Thus, the longer the inspiratory time, the more lung tissue that will be recruited, and the shorter the expiratory time, the less lung tissue that will be allowed to recollapse ([Figure 9](#F9){ref-type="fig"}). A collapsed airway inflates after the opening threshold pressure is reached, and the pressure then propagates down the airway, inflating more airways and alveoli. This process progresses in an avalanche manner with power-law distributions of both the size of and intervals between avalanches ([@B144]; [@B2]). It has been postulated that as the lung opens, the increase in parenchymal tethering of airways ([@B16]) and alveolar interdependence improves lung function as a power-law function ([@B107]). These new perspectives inform the quest for novel protective ventilation strategies. Indeed, our work in translational animal models and a meta-analysis of data on surgical intensive care unit (SICU) patients has shown that our time-controlled adaptive ventilation (TCAV) method, using airway pressure release ventilation (APRV) mode, is highly effective at keeping the lung open and stable, significantly reducing morbidity in translational animal models and reducing the ARDS incidence and mortality rates of SICU patients at high risk of developing ARDS ([@B129]; [@B5]; [@B43]; [@B130]; [@B75], [@B76], [@B74],[@B77], [@B78]; [@B110], [@B111],[@B112], [@B108]; [@B141]; [@B70], [@B71]; [@B135]; [@B139]; [@B89]).

Others have shown the importance of ventilation time on lung mechanics. [@B132] calculated a pressure-time product (PTP)/breath as the integral of the change in esophageal pressure over time. They found that, when using biphasic positive airway pressure, PTP significantly increased when the rate of time-cycled control breaths was at 50 breaths/min as compared to when it was 100 or 75 breaths/min. The energetics of ventilation also contain components of ventilator time. Power is defined as work per unit time and is thus equal to pressure x (volume/time) ([@B93]). Most of the energy applied to the lung during inflation is accounted for in elastic storage and airway resistance. It is postulated that the damage due to power is caused by the energy that is dissipated and unrecovered during exhalation. In addition, it is not just the power but also the changes in the microenvironment that result in tissue damage. Regional alveolar instability can develop during ARDS and can greatly amplify energy dissipation locally. Regional instability acts as a stress-focus, and once a microstrain threshold is reached, the unrecovered energy will cause a rapid progression of lung tissue injury in a power-law fashion ([@B65]).

Eliminating Constraints of Ventilating the Acutely Injured Lung {#S7}
===============================================================

It was recently shown in ARDS patients that low Vt and Pplat do not correlate well with reduced patient mortality, whereas low ΔP correlated strongly with improved survival ([@B3]). The critical lesson is that it is not the settings dialed into the ventilator (i.e., Vt, Pplat, and so on) that are key to improved survival, but rather the impact of these settings on lung physiology measured as a change in ΔP ([@B75], [@B76], [@B77]).

Using the ARDSnet method, the Vt was set at 6 cc/kg, the Pplat was set at \< 30 cm H~2~O, and PEEP was set on a sliding oxygenation scale; the mechanism of improved mortality was assumed to be due to these parameters. The Amato study clearly demonstrated that the mechanism of increased survival was not these desired setting values, because none correlated with outcome ([@B3]). Lower ΔP, on the other hand, strongly correlated with reduced mortality. Respiratory system compliance (C~RS~) was used to calculate driving pressure (ΔP = Vt/C~RS~), which was shown to decrease in patients who survived, reflecting a desirable change in lung physiology caused by recruitment.

The ARDSnet method assumes that the constraints of ventilating a heterogeneously collapsed lung are unavoidable, in which case the Ptp is high due to the high E~spec~ value and low baby lung (FRC) volume. However, if the entire lung could be fully recruited, these constraints would be eliminated, E~spec~ reduced, and FRC increased, resulting in a significant reduction in the applied stress (i.e., Ptp) for any given Vt. Rahaman used a stress equation similar to Eq. 1 to analyze the mathematics of VILI ([@B124]). He concluded that stress increases for any given Vt and PEEP with an increase in respiratory rate (RR). This conclusion assumes that the clinician is constrained in ventilating a heterogeneously collapsed lung such that neither FRC (i.e., the size of the baby lung) nor E~spec~ can be changed. When these conditions are true, the conclusion that Vt, PEEP, and RR must be kept low to reduce stress is correct. Conversely, our perspective is the better strategy is to treat the lung by reinflating the collapsed tissue, increase FRC (eliminating the baby lung), and decreasing E~spec~. This combination will reduce lung stress (Ptp) during ventilation even at higher Vt, PEEP, and RR (Eq. 1).

Of course the strategy of "casting" the broken lung open until it heals would be clinically effective only with a ventilation strategy that could perform such a feat ([@B108]). Unfortunately, the current OLA strategies have not been shown effective at opening and stabilizing the lung ([@B11]; [@B37]; [@B68]; [@B72]; [@B164]), and the recent ART trial showed an increase in mortality using the OLA ([@B17]; [@B97]; [@B99]; [@B26]).

The TCAV Method to Open and Stabilize the Acutely Injured Lung {#S8}
==============================================================

Our TCAV method using the APRV mode has been discussed in detail elsewhere ([@B63]; [@B70]; [@B108], [@B107]; [@B73]). Briefly, TCAV consists of an extended (4--5 s) open valve continuous positive airway pressure (CPAP) phase with a very short (≤0.5 s) release phase. The inspiratory:expiratory ratio is ∼10:1. The open valve allows the patient to spontaneously breath (inspiration or expiration) with little resistance. Tidal volume (Vt) is not set but rather is a product of the CPAP level and lung compliance. A heterogeneously collapsed lung will have a very low Vt because the compliance will be low, but as the lung gradually recruits over time, the compliance will increase and so will the Vt. Since the Vt is set based on lung compliance, a high Vt will never be delivered to a non-compliant collapsed lung using the TCAV method. Thus, the Vt size is personalized and adaptive as the patient's lung gets better or worse, directed by changes in lung compliance. The extended CPAP time will gradually nudge viscoelastic alveoli open over several hours until the lung is fully inflated. The newly recruited alveoli will be prevented from recollapse through the use of a very short expiratory duration (release phase). Expiratory time is very short (≤0.5 s), and thus the lung is reinflated (CPAP phase) before it has time to completely empty, maintaining a TC-PEEP. The very short expiratory time is not sufficient for viscoelastic alveoli to collapse and when combined with the TC-PEEP is highly effective at preventing alveolar derecruitment.

Our group has investigated the physiological impact of the TCAV method in both mechanistic and efficacy animal studies ([@B129]; [@B43]; [@B130]; [@B128]; [@B75], [@B76], [@B74],[@B77], [@B78]; [@B141]; [@B139]) and in a meta-analysis of data on SICU patients ([@B5]). In addition, the TCAV method is the primary ventilator strategy used at the R Adam Cowley Shock Trauma Center in Baltimore, with well over 1,000,000 h of ventilator time. Below, we discuss the results from our animal data and our clinical statistical analysis as evidence for the TCAV method's mechanisms and efficacy.

In rat VILI and hemorrhagic shock models, it was shown that ventilation for 6 h using the TCAV method was superior to volume-controlled ventilation (VCV; Vt 10 ml/kg, PEEP 0.5 cm H~2~O) at preventing the development of ARDS and that lung protection was associated with stabilization of alveoli ([Figure 10](#F10){ref-type="fig"}) ([@B43]; [@B130]). The TCAV method was also shown to be lung protective in a preterm piglet model of infant respiratory distress syndrome ([@B78]). These data were supported by mechanistic studies showing the ability of the TCAV method to normalize alveolar and alveolar duct microanatomy ([@B76]) ([Figure 7](#F7){ref-type="fig"}) and to reduce dynamic alveolar strain ([@B75], [@B77]; [@B141]). We developed a 48-hr clinically applicable, high-fidelity, porcine peritoneal sepsis (PS) plus gut ischemia/reperfusion (I/R), multiple organ dysfunction syndrome (MODS) and ARDS model. In three studies using this clinically applicable model, we demonstrated that the TCAV method was superior to VC or the ARDSnet method at blocking progressive acute lung injury and preventing ARDS development ([Figure 11](#F11){ref-type="fig"}) ([@B129]; [@B128]; [@B74]). In addition, we have shown that surfactant proteins A and B are both better preserved with the TCAV as compared with the ARDSnet method, suggesting that there is sufficient lung volume change with TCAV to preserve stretch-induced surfactant release ([@B129]; [@B43]; [@B130]; [@B128]; [@B74]). Lastly, in a statistical analysis of data from SICU patients, the TCAV method was associated with a significant reduction in ARDS incidence and mortality as compared to standard of care ventilation in 15 SICUs ([Figure 12](#F12){ref-type="fig"}) ([@B5]).

![Left -- Subpleural alveoli seen using *in vivo* microscopy in a rat hemorrhagic shock-induced ARDS model ventilated with volume cycled ventilation (*VC*; **A,B**) or airway pressure release ventilation (*APRV*) using the time controlled adaptive ventilation (TCAV) method (*APRV*; **C,D**). Individual alveoli are shown by arrows. Inflated alveoli were color coded yellow, and alveolar number, size, and surface area were measured by computer image analysis in each group. TCAV significantly improved alveolar patency and stability as compared with the VC group. Right -- The *APRV* group delivered using the TCAV method stabilized alveoli that was associated with a significant reduction in lung histopathology as evidenced by open alveoli and reduced intra-alveolar edema (purple areas) as compared with the collapsed and edema-filled alveoli (stars), fibrinous deposits in the air compartment (arrowheads), and white cell infiltration (between arrows) in the *VC* group ([@B130]). *Permissions obtained from Wolters Kluwer Health, Inc. License 4699411295724.*](fphys-11-00227-g010){#F10}

![Three groups of pigs were ventilated for 48 h with a clinically applicable, high-fidelity porcine peritoneal sepsis (PS) and gut ischemia/reperfusion (I/R) acute respiratory distress syndrome (ARDS) model: (1) *Control* group without PS + I/R injury ventilated with a tidal volume (Vt) of 10 cc/kg and a positive end-expiratory pressure (PEEP) of 5 cm H~2~O. (2) *ARDSnet* group using a low-Vt ventilation method, applied following PS + I/R injury at the time point at which the animal reached the oxygen saturation limit listed in the ARDSnet protocol, with PEEP and FiO~2~ adjusted by oxygenation ([@B6]). (3) Time-controlled adaptive ventilation (*TCAV*) method using the airway pressure release ventilation (APRV) mode applied immediately after PS + I/R injury ([@B63]; [@B70]). **Upper** -- Gross lung photographs after 48 h of ventilation following PS + I/R injury at necropsy (*Control* not shown). In the *TCAV* group **(A,B)**, lungs inflated fully to near total lung capacity at 25 cm H~2~O without any gross atelectasis. The cut surface of the diaphragmatic lobe also showed no interstitial or airway edema and no atelectasis. Lungs in the *ARDSnet* group **(C,D)** also inflated to 25 cm H~2~O showed low lung volume with heterogeneous collapse and atelectasis and were wet and "boggy." The cut surface showed both interstitial and airway edema. **Lower** -- Photomicrographs of representative lung sections of specimens from the *Control* **(A)**, *ARDSnet* **(B)**, and *TCAV* **(C)** groups each at 40× magnification. F, fibrinous deposit in the air compartment; arrow, blood in alveolus; arrowhead, congested alveolar capillary; bracket, thickened alveolar wall. **(A)** *Control*: animals received 48 h of mechanical ventilation without PS + I/R injury. Specimen shows typical early acute lung injury pathology including fibrinous deposits, blood in alveolus, congested capillaries, and thickened alveolar walls. **(B)** *ARDSnet*: animals received PS + I/R injury, and LVt ventilation was applied after the onset of acute lung injury (i.e., PaO~2~/FiO~2~ ratio \<300). Specimen shows typical advanced acute lung injury pathology including fibrinous deposits, blood in alveolus, congested capillaries, leukocyte infiltration, and thickened alveolar walls. **(C)** *TCAV*: specimen shows normal pulmonary architecture, alveoli are well-expanded and thin walled, and there are no exudates ([@B128]). *Permissions obtained from Wolters Kluwer Health, Inc. License 4699411460832.*](fphys-11-00227-g011){#F11}

![A systematic review of data from trauma patients who were ventilated with either conventional mechanical ventilation (CMV) or the time-controlled adaptive ventilation (TCAV) method using the airway pressure release ventilation (APRV) mode. Boxplots are mean and standard error for **(A)** Injury Severity Score (ISS), **(B)** percentage of patients who developed ARDS (ARDS%), and **(C)** in-hospital mortality (%) from 16 published papers using standard of care CMV. Black circles indicate the results in each category using the TCAV method at the *R Adam Cowley Shock Trauma Center* in Maryland. Although patients in the TCAV group were in the high-ISS range, they had the lowest levels of both ARDS incidence (ARDS%) and in-hospital mortality (%) as compared with patients ventilated using CMV ([@B5]). *Permissions obtained from Wolters Kluwer Health, Inc. License 4699420119915.*](fphys-11-00227-g012){#F12}

It is important to remember that if the acutely injured lung can be fully recruited, it will remain *time* and *pressure* dependent (i.e., will collapse quickly at atmospheric pressure) for a period of hours to days ([@B147]). Once the acutely injured lung is opened, the ventilator pressure/time support necessary to keep it open cannot be reduced until the lung "heals." Gradually pulmonary edema will be reabsorbed and surfactant function restored (Vazquez [@B38]). As more and more lung tissue is recruited, reestablishing alveolar interdependence ([Figure 6](#F6){ref-type="fig"}) ([@B96]; [@B91]) and parenchymal tethering ([@B116]), the lung will once again become stable at atmospheric airway pressure, and the weaning process can begin ([@B96]; [@B116]; [@B91]).

Recent RCTs have shown mixed results in ARDS patients using APRV (but not utilizing the TCAV method). [@B165] randomized patients with a PaO~2~/FiO~2~ (P/F) ratio \< 200 to either ARDSnet LVt or APRV with TCAV-like settings. The APRV group demonstrated significant decreases in length of ICU stay, tracheostomy requirement, ventilator days, and mortality. The APRV group also had significant reductions in the need for prone positioning, sedation, and neuromuscular blockade.

[@B81] conducted an RCT in children with ARDS, who were randomized to receive either standard LVt strategy or APRV. The APRV group was shown not to be lung protective, and the trial was terminated early. We postulate the failure was due to fundamental misconceptions as to the MB~P~ necessary to protect the lung. A key objective in our TCAV method is to gradually nudge the lung open. In the Ganesan study, the CPAP pressure was reduced to generate a low Vt, and thus the CPAP level was likely not above the lung critical opening pressure, meaning the lung was not inflated. In the TCAV method, Vt is not set (see TCAV description above), so an increase in release volume (analogous to Vt) during the release phase and an increase in C~RS~ are positive signs and indictive of lung recruitment ([@B129]; [@B128]; [@B74]). If the ventilation strategy used does not actually open the lung, the VILI mechanisms associated with heterogeneous ventilation will not be prevented ([Figure 4](#F4){ref-type="fig"}). We postulate that this is also the reason for the failed RCTs using an RM and titrated PEEP ([@B17]; [@B97]; [@B99]; [@B26]).

[@B67] conducted an RCT in adults, and similarly to the Ganesan study, targeted a Vt at ∼6 mL/kg. The study was stopped early, in part because the Vt often exceeded 12 mL/kg, even though there were no significant differences between groups in pneumothorax, sedation, vasoactive medications, P/F ratio, or outcome ([@B67]). As stated above, when the TCAV method is used, an increase in Vt is indicative of lung recruitment and is a positive effect. Thus, one of the critical protective mechanisms of the TCAV method, the ability to fully open the lung, was not incorporated into the APRV setting in either the Hirshberg or Ganesan study. The conclusion from these clinical studies should not be that "APRV is not lung protective" but rather that the Zhou ([@B165]) and TCAV methods ([@B5]) are superior to the Ganesan ([@B81]) and Hirshberg ([@B67]) methods for lung protection. Two recent statistical reviews and meta-analyses of RCTs have shown the APRV mode is associated with a mortality benefit, improved oxygenation, and a greater number of ventilator-free days when compared with conventional ventilation strategies, without any negative hemodynamic impact or higher risk of barotrauma ([@B23]; [@B84]).

An example of the TCAV method's effectiveness when applied to a patient on extracorporeal membrane oxygenation (ECMO) with respiratory failure is seen in [Figure 13](#F13){ref-type="fig"}. A 35-year-old man with a history of systemic lupus erythematous, with catastrophic antiphospholipid syndrome, underwent a coronary artery bypass graft with mitral valve repair and was placed on protective pressure-control assist-control ventilation (PC-AC) with protective settings using the ARDSnet method. Chest X-rays (CXRs) on PC-AC for 21 days, 15 of those days on ECMO, showed widespread infiltrates ([Figure 13A](#F13){ref-type="fig"}). Another 15 days on ECMO (30 days on ECMO total) and PC-AC showed minimal change in CXRs and worsening lung function assessed by P/F ratio (A: 196, B: 75) ([Figure 13B](#F13){ref-type="fig"}). Conversion to the TCAV method for 2 days resulted in a marked improvement in CXRs and P/F ratio (275) ([Figure 13C](#F13){ref-type="fig"}). After 11 days on TCAV, the patient had a clear CXR and normal P/F ratio (414) ([Figure 13D](#F13){ref-type="fig"}). [Figure 13D](#F13){ref-type="fig"} was 6 h prior to decannulation and liberation from ECMO. After 39 days on PC-AC with worsening lung function, it took only 2 days on the TCAV method to reopen and stabilize the patient's lung, and after 11 days the patient was disconnected from ECMO, extubated, and removed from mechanical ventilation.

![Chest X-rays (CXRs) and blood gases in a patient with respiratory failure on extracorporeal membrane oxygenation (ECMO). **(A)** CXR and blood gases (arterial pH, PCO~2~, and PO~2~ with the calculated PaO~2~/FiO~2~ ratio) at 15 days on ECMO and protective ARDSnet pressure-control assist-control ventilation (PC-AC). Bilateral infiltrates can be seen throughout the lung with a PaO~2~/FiO~2~ ratio of 196. **(B)** After 30 days on ECMO and PC-AC, the patient showed some clearing in the upper right quadrant but a worsening PaO~2~/FiO~2~ ratio of 75. **(C)** Two days after conversion to the TCAV method, the patient showed marked improvement in CXR and PaO~2~/FiO~2~ ratio (275). **(D)** After 11 days on the TCAV method, the patient showed a cleared CXR and normalized PaO~2~/FiO~2~ ratio (414). The patient came off of ECMO and was extubated. *Written informed consent obtained for the use of these images.*](fphys-11-00227-g013){#F13}

Conclusion {#S9}
==========

Current protective ventilation strategies have not significantly reduced ARDS-related mortality in the 20 years since the ARMA study, possibly because strategies are constrained to ventilating the heterogeneously collapsed and unstable lung. In addition, current protective ventilation strategies have not considered all of the physiological parameters necessary to protect the acutely injured lung. Alveoli and alveolar ducts open and collapse as a viscoelastic system such that there is a time lag between when the airway pressure is applied and alveoli open, and between when the airway pressure is removed and alveoli collapse. Loss of pulmonary surfactant function, a key ARDS pathology, amplifies these viscoelastic properties, rendering the lung *time* and *pressure* dependent, such that it takes an extended time at the higher pressure for lung tissue to open and a very brief time, even with an elevated airway pressure, for the lung to recollapse.

This knowledge suggests that to eliminate VILI the ventilation strategy must open and stabilize the lung. Current ventilation strategies attempting this OLA have not reduced mortality in clinical trials. Since alveolar volume change is viscoelastic in nature, the *time* at both inspiration and expiration would be critical to accomplishing the OLA goals. We have developed a time-controlled adaptive ventilation TCAV method using the APRV mode and have shown that it is highly effective at opening and stabilizing the lung, which significantly reduces VILI-induced lung damage in animal ARDS models. We have also shown that preemptive application of the TCAV method in trauma patients significantly reduces ARDS incidence and mortality. Recent RCTs using the APRV mode but not adjusted with the TCAV method have shown mixed results, suggesting that properly adjusted APRV is critical to clinical success.
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